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Abstract
Background: Insomnia is common among elderly people and associated with poor health. The Minimal Insomnia
Symptom Scale (MISS) is a three item screening instrument that has been found to be psychometrically sound and
capable of identifying insomnia in the general population (20-64 years). However, its measurement properties have
not been studied in an elderly population. Our aim was to test the measurement properties of the MISS among
people aged 65 + in Sweden, by replicating the original study in an elderly sample.
Methods: Data from a cross-sectional survey of 548 elderly individuals were analysed in terms of assumptions of
summation of items, floor/ceiling effects, reliability and optimal cut-off score by means of ROC-curve analysis and
compared with self-reported insomnia criteria.
Results: Corrected item-total correlations ranged between 0.64-0.70, floor/ceiling effects were 6.6/0.6% and
reliability was 0.81. ROC analysis identified the optimal cut-off score as ≥7 (sensitivity, 0.93; specificity, 0.84; positive/
negative predictive values, 0.256/0.995). Using this cut-off score, the prevalence of insomnia in the study sample
was 21.7% and most frequent among women and the oldest old.
Conclusions: Data support the measurement properties of the MISS as a possible insomnia screening instrument
for elderly persons. This study make evident that the MISS is useful for identifying elderly people with insomnia-like
sleep problems. Further studies are needed to assess its usefulness in identifying clinically defined insomnia.
Background
According to the International Classification of Sleep
Disorders, second edition (ISCD-2), the diagnosis of
insomnia is based on a subjective report of difficulties
initiating sleep, maintaining sleep due to night time or
early morning waking or non-restorative sleep, despite
ideal sleep conditions, leading to daytime impairments
[1-3]. Secondary insomnia is the most common form
and can be related to an underlying somatic or psychic
disease or pharmaceutical use [4].
Many elderly people suffer from one or more chronic
medical conditions that can cause or contribute to sleep
difficulties [5]. Persistent insomnia in elderly persons is
often associated with co-morbidity, use of medication or
other primary sleep disorders [6]. Common sleep
difficulties among elderly people include waking at night
and longer periods of wakefulness before falling asleep
again [7-9].
Sleep difficulties, such as persistent insomnia, are
associated with immune system changes [10], the devel-
opment of diseases such as depression as well as
impaired memory function and ability to concentrate
and make decisions [11,12]. Consequently insomnia also
has societal and economic implications and is for exam-
ple associated with an elevated risk of disability pension
[13]. However, while a significant minority of the adult
population has at least one insomnia symptom occur-
ring three nights or more per week, the majority do not
seek help. This can be explained by lack of knowledge
about insomnia in the general population but also by
under-recognition and under-diagnosis on the part of
health care personnel. It is important to take symptoms
of insomnia seriously [14], since they tend to become
persistent [1].
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age and is more common among women [7]. In persons
aged 65 years or over, the risk of developing insomnia is
73% greater in women than men [15]. Elderly people are
a vulnerable group, and long questionnaires may be per-
ceived as tiresome to fill in, not only by the elderly indi-
viduals themselves but also by health care personnel. A
short screening instrument that could identify persons
with self-reported insomnia would therefore be useful.
The Minimal Insomnia Symptom Scale (MISS) was
developed from a more extensive sleep questionnaire
and is a brief, three item screening instrument [1]. The
basic psychometric properties of the MISS were evalu-
ated in a randomly selected general population (n =
1075) aged between 20 and 64 years, and the prevalence
of insomnia was found to be 22.5%. Although the find-
ings support the measurement properties of the MISS as
an insomnia screening instrument, the extent to which
these data are applicable to an elderly population is still
unknown. Our aim was to test the measurement proper-
ties of the MISS among people aged 65 + in Sweden, by
replicating the original study [1] in an elderly sample.
Methods
Design and study sample
The study, which had a cross-sectional explorative
design, was conducted within the Swedish National
Study on Ageing and Care - Blekinge (SNAC-B) longitu-
dinal study, which is part of the Swedish National Study
on Ageing and Care [16]. The SNAC-B population con-
sists of elderly persons living in Karlskrona municipality,
which is situated in the south-east of Sweden and com-
prises both urban and rural areas. When the SNAC-B
was launched in 2001, 1402 persons agreed to partici-
pate. The SNAC-B target sample, 59.4% of which were
women, included ten age clusters representing the age-
ing population of Sweden. There was a randomized
selection of the younger age clusters (60, 66, 72 and 78
year olds) as well as a total inclusion of the clusters of
people aged 81, 84, 87, 90, 93 and 96 years at baseline
[16]. In 2008, when the data collection for the present
study took place, 978 persons were still alive and regis-
tered as participants, of whom 892 were available for
participation.
The original ten age clusters used in SNAC-B were
amalgamated into three clusters for this study; 65-74
years (including the 67 and 73 year olds), 75-89 years
(including the 79, 85 and 88 year olds) and 90+ (includ-
ing those aged 91 years or older). The distribution of
individuals across the age clusters and in terms of gen-
der is described in Table 1. Approximately 19.1% of the
population of Karlskrona municipality is 65 years or
older, which is a slightly higher age composition com-
pared to Sweden as a whole [16].
Procedure
The study was approved by the regional Ethical Review
Board in Lund (LU 605-00, LU 744-00, 178/2008). In
December 2008, questionnaires were mailed to the 892
persons participating in the SNAC-B study together
with a consent form and a pre-stamped response envel-
ope. Six weeks later, a reminder was sent to those who
had not yet returned the questionnaire. All participants
had the possibility to withdraw from the study at any
time without having to give a reason and were assured
of confidentiality.
Questionnaire
T h es u r v e yc o n s i s t e do ft h eU p p s a l aS l e e pI n v e n t o r y2 5
(USI-25) and three additional questions concerning age,
sex and ability to fill out the form (independently, with
help from a relative/friend or home care personnel).
The USI-25 is a 25 item self-report questionnaire
about sleep difficulties and habits [1] previously used in
studies of sleep associated with specific health condi-
tions [17-19], among the elderly [20] and in longitudinal
studies [21,22]. The USI-25 includes MISS, which con-
sists of three items describing the major features of
insomnia, i.e. difficulties initiating sleep, waking at night
and not feeling refreshed by sleep [1]. Each item has five
response alternatives; no problem (0), small problems
(1), moderate problems (2), severe problems (3) and
very severe problems (4). This yields a total score ran-
ging between 0 and 12, where higher scores indicate
more severe insomnia. A cut-off score of ≥6o nt h e
MISS has previously been suggested for identifying
insomniacs in the general adult population between 20
and 64 years old (sensitivity 0.82; specificity 0.86; posi-
tive predictive value 0.44; negative predictive value 0.95).
The average item-total correlation was 0.55 and reliabil-
ity (coefficient alpha) was 0.73. Validation against self-
reported indices of insomnia criteria (confirmatory
answers about suffering from sleep difficulties at least
three times per week for a minimum duration of one
month in addition to major daytime impairments due to
poor sleep) supported the instrument’s validity [1].
Data analysis
Analyses were conducted using SPSS 17.0, (SPSS Inc
Chicago, IL.) P-values < 0.05 were considered statisti-
cally significant.
Table 1 Distribution of the study sample
Age-group Male (%) Female (%) Total (%)
65-74 119 (51.1) 146 (46.3) 265 (48.4)
75-89 92 (39.5) 131 (41.6) 223 (40.7)
90+ 22 (9.4) 38 (12.1) 60 (10.9)
Total 233 (42.5) 315 (57.5) 548 (100)
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into a total score in accordance with the Likert tradi-
tion were tested, i.e. item mean scores, standard devia-
tions and corrected item-total correlations should be
fairly similar across items. Furthermore, there should
be evident that items represent a common variable.
This was considered supported if corrected item-total
correlations were ≥0.4 [23]. Floor and ceiling effects
(i.e., the proportion of people with minimum and max-
imum scores respectively) and score reliability (coeffi-
cient a) were then calculated. Floor and ceiling effects
should not exceed 15% [24] and reliability should be
between 0.7 and 0.9 [25].
We then examined the ability of the MISS scores to
identify persons with self-reported insomnia and
explored different cut-off scores. A criterion variable
was constructed by amalgamating three USI-items
regarding daytime sleepiness, feeling physically tired
after sleep and experiencing sleep difficulties. This
variable served as a proxy gold standard against which
the MISS scores could be compared. Respondents who
reported the presence of severe or very severe pro-
b l e m so nt h e s ei t e m sw e r ec o n s i d e r e dt os u f f e rf r o m
insomnia. Although our criterion variable differs from
that used in the original MISS publication [1], it agrees
with some of the insomnia criteria described in the
ICSD-2, such as daytime sleepiness, fatigue and con-
cerns about sleep [3]. A receiver operating characteris-
t i c( R O C )c u r v ew a st h e nd r a w na n dt h ea r e au n d e r
the ROC curve (AUROC) was calculated. The ROC-
curve illustrates the discriminating abilities of a test at
different cut-off values [26]. Based on the ROC-curve,
sensitivity and specificity were calculated for various
cut-off scores. Sensitivity is the ability to diagnose a
condition correctly, while specificity measures the abil-
ity to accurately identify non-cases. These values pro-
vide an indication of the discriminatory abilities of the
scale [27]. In addition, the positive predictive value
(PPV) and negative predictive value (NPV) were calcu-
lated. These values depend not only on sensitivity and
specificity but also on the prevalence of the condition
in question [27,28]. PPV and NPV represent the prob-
ability of a certain outcome when the screening results
(i.e. whether scores are above or below a certain cut-
off) are known.
When sensitivity and specificity are considered
equally important, Youden’s index (sensitivity + specifi-
city -1) can be used to choose an appropriate cut-off
value. Since the maximum value of Youden’si n d e xi s
1, indicating a perfect test, the cut-off score associated
with the highest Youden index (J) is considered opti-
mal [29]. Finally, the prevalence of insomnia (including
95% confidence intervals) according to the MISS was
determined.
Results
Description of the study sample
Of the 892 questionnaires, 548 were returned together
with a signed informed consent form, yielding a
response rate of 61.4% (Figure 1). The mean age of the
respondents was 77.8 (SD 8.63) years. The distribution
of respondents across genders and the three age clusters
are presented in Table 1. Common reasons for declining
participation were advanced age, illness, vision disability,
being unable to obtain help to fill in the questionnaire
or feeling tired. The external drop out (Table 2) mainly
represents persons of advanced age and those with car-
diovascular disease or type-2 diabetes. Most of the parti-
cipants (n = 479; 87.5%) completed the questionnaire on
t h e i ro w n ,w h i l e6 6( 1 2 % )o b t a i n e dh e l pf r o mar e l a t i v e
or friend and three (0.5%) received assistance from
health care personnel.
Responses to the USI-25 items revealed that close to a
third (28.5%) of the sample considered themselves to
suffer from sleep difficulties (9 persons failed to answer
this question). Regular use of sleep medication was
found to increase with age; 5.0% of those aged 65-74
years used sleep medication very often, while the corre-
sponding figure among the oldest old was 24.1%. There
Figure 1 Invited participants and drop-outs.
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cation users. The highest proportion of daytime impair-
ments (i.e., daytime sleepiness, feeling physically tired
after sleep and reporting sleep difficulties) was found
among the 65-74 year olds (7.1%), whereas only 3.8% of
the oldest old reported such impairments. Interestingly,
of those who claimed to have no sleep difficulties, 317
reported insomnia symptoms on the MISS. There were
more women than men that reported insomnia symp-
toms (Table 3).
Measurement properties of the MISS
Fifty-one persons (9.3%) failed to fill in all the MISS
items, thus complete MISS data were obtained from a
total of 497 individuals. Mean MISS item scores ranged
between 1.2-1.7 (SD 1.0-1.2) and corrected item-total
correlations between 0.64-0.70. Inter-item correlation
ranged between 0.55-0.62. Reliability was 0.81. Floor and
ceiling effects were 6.6 and 0.6%, respectively.
The criterion validity of the MISS was tested against
the amalgamated criterion variable which corresponds
with some of the diagnostic criteria in the ICSD-2 [3].
The MISS ROC-curve is presented in Figure 2. The area
under the curve was 0.935 (95% CI: 0.90-0.97; P <
0.001), indicating good correspondence between the cri-
terion variable and the MISS. According to the Youden
i n d e x ,ac u t - o f fM I S Ss c o r eo f≥7w a sf o u n dt h em o s t
optimal (Table 4).
Prevalence of insomnia
The mean MISS score for the total sample was 4.11
(95% CI, 3.86-4.35). The prevalence of self-reported
insomnia in this sample of elderly persons based on var-
ious MISS cut-off scores can be seen in Table 5. Using
ac u t - o f fo f≥7, the overall prevalence of insomnia was
21.7% (95% CI, 18-25%). Insomnia tended to be more
common among persons aged 90 years or over (24.1%)
and affected more women (26.8%) than men (15.2%).
Among those identified as insomniacs, 12.3% answered
“no” to the question of perceived sleep difficulties.
Discussion
This study tested the measurement properties of a brief
insomnia screening instrument, the MISS, among elderly
persons. Previous testing of the MISS in the general
population under 65 years of age, found it to be sound
Table 2 Characteristics of non-participants vs.
participants
Variables Non-participants
(n = 344)
Participants
(n = 548)
p-value
1
Age mean (SD) 83.2 (9.8) 77.8 (8.6) < 0.001
Sex 0.302
Female % 39.9 60.1
Male % 36.2 63,8
Angina Pectoris % 48.8 51.2 0.014
Arthritis % 43.0 57.0 0.183
Cancer % 43.0 57.0 0.328
Chronic heart failure % 62.2 37.8 0.001
Depression % 43.9 56.1 0.236
Diabetes type 2 % 53.8 46.2 0.012
Hypertension % 44.8 55.2 0.019
Osteoporosis % 55.2 44.8 0.084
1) Chi-square test and Mann-Whitney U-test. For the Chi-square test Yates’
correction has been used.
Internal drop-out on variables was 0-1.2% accept for osteoporosis (10.5%) and
arthritis (17.1%).
Table 3 Sleep difficulties found among the elderly
persons
Sleep difficulty Female Male 65-74 75-89 90+
Difficulties initiating sleep % 18.6 9.1 13.8 15.5 13.8
Difficulties maintaining sleep % 22.3 15.6 19.5 18.7 21.4
Not being refreshed % 18.2 12.8 17.8 14.2 13.2
No insomnia symptoms % 5.4 8.3 5.8 8.9 1.9
One insomnia symptom % 16.8 12.0 13.4 16.4 13.2
Two insomnia symptoms % 10.4 6.9 9.1 8.9 7.5
Three insomnia symptoms % 6.4 3.7 6.2 3.9 5.7
Insomnia symptom = reports of severe/very severe problems with initiating
sleep, maintaining sleep or not being refreshed by sleep.
Figure 2 Receiver operation characteristic curve.
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further support for the usefulness of the MISS and
extends its application to include elderly persons. How-
ever, our findings differ somewhat from the previous
study in terms of suggested cut-off score and diagnostic
ability. Based on available MISS data we also consider
possible developments of the MISS in order to enhance
its usefulness, by specifying the response alternatives
and add a fourth item comprising daytime impairments.
The screening capacity of the MISS in this study
(AUROC, 0.94; 95%CI, 0.9-0.97) was similar to that
reported in a younger adult population ( AUROC, 0.92;
95%CI, 0.89-0.94) [1]. But a cut-off value ≥7w a sf o u n d
more suitable than that of ≥6 previously identified in
y o u n g e ra d u l t s[ 1 ] .T h i sd i v e r g e n c em a yb ed u et ot h e
variation in size and age of the study samples, as well as
the use of different gold standards. It is possible that
healthy, elderly persons perceive disturbed sleep and
daytime impairments as related to the advanced age.
The proxy-gold standard used in this study prerequisite
recognition of daytime impairments. There is thus a risk
that the prevalence of insomnia is under-recognized.
This would also have bearing on the reported positive
predicted value. Similarly to the previous study [1] MISS
scores were not directly tested against diagnostic insom-
nia criteria but a proxy gold standard was used instead.
However, the proxy gold standard was not the same as
in the original study. While this may explain the
observed differences in result, future studies should con-
sider testing the MISS directly against diagnostic insom-
nia criteria in order to provide support for the
legitimacy of creating a total MISS score that is reliable,
unidimensional and valid in people aged 65 years or
older.
Ac u t - o f fv a l u eo f≥7 revealed a 21.7% prevalence of
insomnia in the present study. In previous testing of the
MISS in the general population using a cut-off value of
≥6, the prevalence of insomnia was found to be 22.5%
[1]. This shows a similarity between the studies in esti-
mating the prevalence of insomnia symptoms. Other
studies have found that insomnia symptoms occur in
33-50% of the adult population, while the prevalence of
insomnia disorder has been estimated to about 10-30%
[14,30-32]. In relation to these figures, the MISS appears
to blunt for diagnosing insomnia.
Therefore, if the goal is to diagnose insomnia, addi-
tional investigations based on clinical diagnostic criteria
are needed, as pointed out by the constructors of the
MISS [1]. The MISS should thus be regarded as an
initial screening instrument. Although its brevity is
advantageous in the inclusion of only three items also
limits the usefulness of the MISS. It appears reasonable
to suggest that the MISS would benefit from adding a
fourth item concerning daytime impairments which is
among the diagnostic criteria for insomnia [3]. Similarly,
it could also be considered to incorporate some refer-
ences to the duration and frequency of the sleep diffi-
culties specified by the MISS items, possibly by
integrating this with the response options. Compared to
other available short insomnia screening questionnaires,
which contain 6-10 items [33-35], such an expansion of
the MISS would still render the briefest insomnia
screening questionnaire.
Healthy elderly persons adjust their expectations of
sleep, accepting the changes as a normal part of aging.
It has been suggested that it is the individual’s perspec-
tive of growing old that is significant for the experience
of good or poor sleep. The presence of a medical disease
or chronic illness has stronger correlations with poor
sleep than chronological age per se [36,37]. Women also
appear to accept sleep loss as a natural part of life.
Sociologists consider that women indeed recognize sleep
Table 4 MISS cut-off values, sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV)
and Youden’s index
Cut-off score Sensitivity Specificity 1-specificity PPV NPV Youden’s index
≥5 0.963 0.643 0.357 0.137 0.997 0.606
≥6 0.926 0.752 0.248 0.181 0.994 0.678
≥7 0.926 0.838 0.162 0.256 0.995 0.764
≥8 0.815 0.920 0.080 0.377 0.988 0.730
Table 5 Prevalence of insomnia according to different MISS cut-off scores
Cut-off Mean score
(95%CI)
All
(n = 497)
Male
(n = 217)
Female
(n = 280)
65+
(n = 242)
75+
(n = 201)
90+
(n = 54)
≥5 6.91 (6.67-7.15) 202 (40.6%) 69 (31.8%) 133 (47.5%) 99 (40.9%) 82 (40.8%) 21 (38.9%)
≥6 7.57 (7.33-7.81) 150 (30.2%) 51 (23.5%) 99 (35.4%) 71 (29.3%) 62 (30.8%) 17 (31.5%)
≥7 8.19 (7.94-8.44) 108 (21.7%) 33 (15.2%) 75 (26.8%) 52 (21.5%) 43 (21.4%) 13 (24.1%)
≥8 8.97 (8.68-9.26) 65 (13.0%) 21 (9.6%) 44 (15.7%) 32 (13.2%) 23 (11.4%) 10 (18.5%)
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social roles determines to which extent they can access
adequate sleep. Over time the social roles in life of the
women, conceal the sleep disruption until poor sleep
patterns becomes the norm [38]. This could imply that
women and elderly persons are inattentive to insomnia
symptoms, contributing to the under-diagnosis of the
disorder. Our findings reveal that insomnia is more pre-
valent in women and in the oldest old. However, the
MISS is a self-report questionnaire, reflecting subjective
experiences rather than the prevalence of insomnia dis-
order, which is problematic when comparing groups.
Objective measures could yield a different result [39].
Furthermore, previous research has found that self-
reports of polysomnographically measured sleep are less
accurate and valid in older persons compared to
younger [36].
Limitations
There are limitations in the design of the study that
need to be considered. A concern arose when using the
USI-25 questionnaire, particularly when trying to vali-
date the MISS, as the former contains no measure of
the duration or frequency of sleep difficulties, nor day-
time impairments. This makes it difficult to establish a
clinical diagnosis of insomnia, as such a diagnosis is
based on the duration of the sleep difficulty, impaired
daytime functioning and the three major symptoms [3].
However, it was considered important not to increase
respondent burden by using multiple questionnaires,
due to the vulnerability of the study sample and the risk
of further compromising the response rate.
Another limitation was the cross-sectional design.
Repeated measures could have contributed to more
robust reliability and validity [40]. Furthermore, the
study design did not allow for any testing of sensitivity
to change in order to verify or reject previous findings
[1], which have provided some support for responsive-
ness of the MISS.
As the respondents participated in the SNAC-B study,
we had access to data about the prevalence of different
diseases in the sample, which was used when analysing
the external drop out. The external drop-out analysis
revealed that persons with cardiovascular disease and
diabetes, who could be expected to suffer from insomnia
[41,42], chose to decline participation, which may have
influenced the findings. Furthermore, the MISS has not
been tested as an independent instrument but was
extracted from the USI-25 questionnaire, which may
have implications for the response rate in the present
study. Finally, future studies on the MISS should con-
sider using more advanced psychometric methods, such
as Rasch analysis or item response theory.
Conclusion
This is the first study of the measurement properties of
the MISS in an elderly population, and our observations
provide support for its reliability and validity in elderly
persons in Sweden. As such, the results provides further
support that the MISS is useful for identifying elderly
persons with insomnia-like sleep problems who would
be candidates for more detailed assessments. However,
further studies are needed to assess its usefulness in
identifying clinically defined insomnia.
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